News

Newsmogrifydigital2021-11-02T09:15:40+00:00

FEATURED

CONTENT

Mogrify appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor

Tom Graney has been appointed to our Board of Directors as Non-Executive Director, Audit Chair and Capital Markets Advisor.

Tom has over 25 years’ of diverse and rich experience in biopharma that spans corporate development, commercial strategy, portfolio management, and value creation. He joins senior biopharma industry executives, Dr. Jane Osbourn OBE (Chair) and Dr. Lorenz Mayr, as an independent member of the Board of Directors.

Latest

NEWS

Mogrify appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor

Mark Cavanagh2022-05-09T10:41:16+00:002nd November 2021|

Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer

Mark Cavanagh2022-05-09T10:41:26+00:005th October 2021|

Mogrify completes Series A financing totaling $33 million USD

Mark Cavanagh2022-05-09T10:41:36+00:004th May 2021|

Mogrify wins Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at CambridgeshireLive Business Excellence Awards 2020

Mark Cavanagh2022-05-09T10:42:08+00:0026th March 2021|

Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology

Mark Cavanagh2022-05-09T10:42:14+00:0011th January 2021|

Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversion

Mark Cavanagh2022-05-09T10:42:22+00:0017th December 2020|

Load More Posts

Latest

Resources

VIEW ALL RESOURCES

VIEW ALL MEDIA FEATURES

VIEW ALL EVENTS

Follow Us On

Social Media